glp 1 gip dual agonist mechanism of action Understand GLP-1/GIP Tirzepatide and Its Effect on Current Weight Loss Therapy Glucagon-like Peptide 1, Glucose-Dependent Insulinotropic
Description
Gut microbiota-mediated inflammation in obesity: a link with gastrointestinal cancer
Intracranial pressure outcomes Direct assessment of ICP was limited to the single included RCT by Mitchell et al
These include SGLT2 inhibitors, optimised insulin regimens, structured education programs and targeted lifestyle support
Effect of 12-week dulaglutide therapy in Japanese patients with biopsy-proven non-alcoholic fatty liver disease and type 2 diabetes mellitus
YX reports consulting (uncompensated) for Pfizer
metformin was generally the background therapy for the majority of subjects
